Medicure (MCUJF) Cash & Equivalents (2009 - 2026)

Medicure's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 77.64% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 77.64% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 47.74% from the prior year.
• Cash & Equivalents retreated to $1.1 million in Q1 2026 per MCUJF's latest filing, from $2.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $5.1 million in Q4 2024 and bottomed at $1.1 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $3.6 million (2023), against an average of $3.7 million.
• Across the five-year window, Cash & Equivalents jumped 89.34% in 2022 and tumbled 77.64% in 2026, its largest moves.
• Year by year, Cash & Equivalents stood at $3.6 million in 2022, then jumped by 30.74% to $4.7 million in 2023, then grew by 10.03% to $5.1 million in 2024, then sank by 46.58% to $2.8 million in 2025, then plunged by 59.11% to $1.1 million in 2026.
• Per Business Quant, the three latest MCUJF Cash & Equivalents figures stand at $1.1 million (Q1 2026), $2.8 million (Q4 2025), and $3.0 million (Q3 2025).